果园 发表于 2025-3-21 19:10:06

书目名称Cancer Immunology: Innovative Approaches to Therapy影响因子(影响力)<br>        http://impactfactor.cn/2024/if/?ISSN=BK0221133<br><br>        <br><br>书目名称Cancer Immunology: Innovative Approaches to Therapy影响因子(影响力)学科排名<br>        http://impactfactor.cn/2024/ifr/?ISSN=BK0221133<br><br>        <br><br>书目名称Cancer Immunology: Innovative Approaches to Therapy网络公开度<br>        http://impactfactor.cn/2024/at/?ISSN=BK0221133<br><br>        <br><br>书目名称Cancer Immunology: Innovative Approaches to Therapy网络公开度学科排名<br>        http://impactfactor.cn/2024/atr/?ISSN=BK0221133<br><br>        <br><br>书目名称Cancer Immunology: Innovative Approaches to Therapy被引频次<br>        http://impactfactor.cn/2024/tc/?ISSN=BK0221133<br><br>        <br><br>书目名称Cancer Immunology: Innovative Approaches to Therapy被引频次学科排名<br>        http://impactfactor.cn/2024/tcr/?ISSN=BK0221133<br><br>        <br><br>书目名称Cancer Immunology: Innovative Approaches to Therapy年度引用<br>        http://impactfactor.cn/2024/ii/?ISSN=BK0221133<br><br>        <br><br>书目名称Cancer Immunology: Innovative Approaches to Therapy年度引用学科排名<br>        http://impactfactor.cn/2024/iir/?ISSN=BK0221133<br><br>        <br><br>书目名称Cancer Immunology: Innovative Approaches to Therapy读者反馈<br>        http://impactfactor.cn/2024/5y/?ISSN=BK0221133<br><br>        <br><br>书目名称Cancer Immunology: Innovative Approaches to Therapy读者反馈学科排名<br>        http://impactfactor.cn/2024/5yr/?ISSN=BK0221133<br><br>        <br><br>

promote 发表于 2025-3-21 23:35:11

http://reply.papertrans.cn/23/2212/221133/221133_2.png

neolith 发表于 2025-3-22 02:17:37

http://reply.papertrans.cn/23/2212/221133/221133_3.png

coagulate 发表于 2025-3-22 06:32:06

Monoclonal Antibody Therapy of Cancer: Preclinical Models and Investigations in Humans,ell extracts, these monoclonal antibodies are mouse immunoglobulins. It is possible that the mouse will recognize antigenic determinants on the human tumor cell not well recognized by the patient’s own immune system.

esculent 发表于 2025-3-22 10:34:32

0927-3042 fferent focus or emphasis from that of the first volume, published two years ago. That work (Basic and Clinical Tumor Immunology, R.B. Herberman, ed., Martinus Nijhoff Publishers, 1983) devoted considerable attention to up­ dated summaries in various areas of classical tumor immunology: specific ant

Traumatic-Grief 发表于 2025-3-22 15:37:23

https://doi.org/10.1007/978-1-349-24977-0tent and successful immunotherapy of human cancer remains an elusive goal . Understanding the complex mechanisms regulating macrophage-mediated tumor cell destruction may ultimately lead to a rational basis for immunomodulation and, hence, successful immunologically based therapy of neoplastic diseases.

Traumatic-Grief 发表于 2025-3-22 18:04:08

http://reply.papertrans.cn/23/2212/221133/221133_7.png

减去 发表于 2025-3-23 00:47:45

Book 1986cus or emphasis from that of the first volume, published two years ago. That work (Basic and Clinical Tumor Immunology, R.B. Herberman, ed., Martinus Nijhoff Publishers, 1983) devoted considerable attention to up­ dated summaries in various areas of classical tumor immunology: specific antitumor imm

图画文字 发表于 2025-3-23 04:25:21

http://reply.papertrans.cn/23/2212/221133/221133_9.png

Dri727 发表于 2025-3-23 05:49:18

http://reply.papertrans.cn/23/2212/221133/221133_10.png
页: [1] 2 3 4
查看完整版本: Titlebook: Cancer Immunology: Innovative Approaches to Therapy; Ronald B. Herberman (Director) Book 1986 Martinus Nijhoff Publishers, Boston 1986 Ant